查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933339

安全采血针市场规模、占有率、成长、全球产业分析：依类型、应用、区域洞察和预测（2026-2034 年）

Safety Lancets Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 请询问到货日

价格

安全采血针市场成长驱动因素

全球安全采血针市场规模在 2025 年预计将达到 12.1 亿美元，2026 年将成长至 13.4 亿美元，到 2034 年将达到 32.8 亿美元，在预测期内复合年增长率 (CAGR) 将达到 11.81%。安全采血针是一种专用于血液采集的医疗器械，主要用于糖尿病管理和其他诊断应用。这些器械配备了安全功能，旨在保护医护人员和患者，并最大限度地减少针刺伤。

糖尿病和其他慢性疾病的日益普遍、促进安全医疗实践的技术创新以及监管压力是推动市场成长的关键因素。 到 2025 年，北美将引领市场，占全球 37.74% 的市场占有率，这主要归功于糖尿病的高发病率以及血糖监测产品的重要报销计划。

市场动态

驱动因素：糖尿病发生率的上升是安全采血针市场的主要驱动因素。根据健康指标与评估研究所 (IHME, 2023) 的数据显示，全球有超过 5 亿人患有糖尿病。人们对居家监测解决方案、便利性和微创采血方法的日益青睐进一步推动了市场需求。病人越来越重视舒适性和坚持定期检测，这使得安全采血针成为有效疾病管理的重要工具。

限制因素：高昂的成本仍然是一个挑战，尤其是在发展中地区。 安全采血针的价格通常为每100支4.87至5.06美元，而传统采血针的价格为每100支2.37至4.22美元，这限制了价格敏感型医护人员和病患的使用。

机会：家庭医疗监测的普及带来了巨大的机会。全球范围内，自我血糖监测（SMBG）正在兴起。 2023年发表在 "印度医学专科杂誌" 上的一项研究报告称，35%的患者使用血糖仪在家进行SMBG。安全采血针易于使用，且针刺伤风险较低，因此非常适合家庭使用。

挑战：发展中国家医疗保健支出的限制阻碍了市场成长。例如，孟加拉的医疗保健支出仅占GDP的2.34%，公共医疗保健预算较低，阻碍了先进设备的广泛应用。

市场趋势

一个关键趋势是向自动/压力启动式安全采血针的转变。自动针头回缩机制和降低损伤风险备受重视。研究表明，自动采血针可以减轻疼痛，并提高临床和家庭护理的效率。

细分市场分析

依类型：

  • 依钮式采血针占主导地位，预计到2026年将占62.57%的市场占有率，这主要归功于其易用性和简单的启动机制。
  • 压力/触摸式采血针可提供一致的穿刺深度和更高的安全性，因此在已开发地区越来越受欢迎。

依切口类型：

  • 针式采血针因其安全特性和减轻疼痛而占主导地位。
  • 刀片式采血针的使用日益普及，尤其是在新生儿筛检和干血斑检测领域，能够采集更多血液样本用于特定诊断。

依年龄组别划分：

  • 由于血糖、糖化血红素 (HbA1c) 和胆固醇检测的频率较高，成人是主要消费族群。
  • 儿科市场预计将迎来成长，这主要得益于第 1 型糖尿病监测和血糖自我监测 (SMBG) 的推广。

依应用程式划分：

  • 受糖尿病高发生率的推动，血糖监测预计将保持领先地位，到 2026 年市占率将达到 59.67%。
  • 血红素检测预计将实现最快成长，而胆固醇检测的普及率适中。
  • 其他应用包括血脂分析、凝血监测和干血斑检测。

依最终使用者划分：

  • 预计到 2026 年，医院和诊所将保持领先地位，市场占有率将达到 41.40%，这主要得益于患者就诊量和辅助监测项目的普及。
  • 由于血糖自我监测 (SMBG) 的广泛应用，家庭医疗保健预计将实现最高的复合年增长率 (CAGR)。
  • 其他市场包括血库、诊断实验室、学术机构和养老院。

区域展望

  • 北美：预计到 2025 年，该市场规模将达到 4.6 亿美元，到 2026 年将达到 5.1 亿美元，这主要得益于糖尿病的高发病率和强有力的报销政策。
  • 欧洲：凭藉先进的医疗保健基础设施，英国（2026年预计3000万美元）和德国（2026年预计1亿美元）是关键市场。
  • 亚太地区：得益于国内製造商和庞大的糖尿病人口，预计到2026年，日本（4000万美元）、中国（1.5亿美元）和印度（8000万美元）将实现最高的复合年增长率。
  • 拉丁美洲：由于医疗保健支出增加和对家庭监测的需求不断增长，预计该地区将实现成长。
  • 中东和非洲：由于糖尿病意识的提高和有利的政策，该地区预计将保持稳定成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家和地区主要疾病盛行率（2025 年）
  • 主要国家和地区自我血糖监测使用者数量（2025 年）
  • 安全采血针的进展
  • 概述：报销方案
  • 主要产业趋势（併购、合作）等等）

第五章 全球安全采血针市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测 - 依类型划分
    • 依钮式
    • 压力/触摸式
  • 市场分析、洞察与预测 - 依切口类型划分
    • 针头式
    • 刀片式
  • 市场分析、洞察与预测 - 依年龄组别划分
    • 成人
    • 儿童
  • 市场分析、洞察与预测 - 依应用划分
    • 血糖监测
    • 血红素检测
    • 胆固醇检测
    • 其他
  • 市场分析、洞察与预测 - 依最终用途划分用户
    • 医院和诊所
    • 家庭医疗保健
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美安全采血针市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲安全采血针市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 美国王国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区安全采血针市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲安全采血针市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章中东与非洲安全采血针市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • BD
    • SARSTEDT AG &Co. KG
    • Greiner Bio-One International GmbH
    • HTL-STREFA (MTD Medical Technology and Devices)
    • Terumo Medical Corporation
    • B. Braun SE
    • Abbott
    • Cardinal Health
    • YPSOMED
    • Biosense Technologies Private Limited
Product Code: FBI113261

Growth Factors of safety lancets Market

The global safety lancets market was valued at USD 1.21 billion in 2025 and is projected to grow to USD 1.34 billion in 2026, reaching USD 3.28 billion by 2034, registering a robust CAGR of 11.81% during the forecast period. Safety lancets are specialized medical devices designed for blood sampling, primarily used for diabetes management and other diagnostic applications. These devices incorporate safety features to minimize accidental needle-stick injuries, enhancing protection for both healthcare providers and patients.

The growing prevalence of diabetes and other chronic diseases, along with technological innovations and regulatory pressures promoting safer medical practices, are key factors driving market growth. North America led the market in 2025, accounting for 37.74% of the global share, due to the high incidence of diabetes and significant reimbursement programs for blood glucose monitoring products.

Market Dynamics

Drivers: The increasing incidence of diabetes is a major driver of the safety lancets market. According to the Institute for Health Metrics and Evaluation (2023), over half a billion individuals globally are living with diabetes. The rising preference for home monitoring solutions, convenience, and less invasive blood sampling methods further propel demand. Patients increasingly seek comfort and compliance in regular testing routines, making safety lancets essential tools for effective disease management.

Restraints: High cost remains a challenge, especially in developing regions. Safety lancets typically cost USD 4.87-5.06 per 100 lancets, compared to USD 2.37-4.22 for traditional lancets, limiting adoption among price-sensitive healthcare providers and patients.

Opportunities: The growing trend of home healthcare monitoring presents significant opportunities. Self-monitoring of blood glucose (SMBG) is increasing globally; a 2023 study in the Indian Journal of Medical Specialties reported that 35% of patients used glucometers for SMBG at home. Safety lancets are well-suited for home use due to ease of use and reduced risk of needle-stick injuries.

Challenges: Limited healthcare spending in developing countries restricts market growth. Low public healthcare budgets, such as Bangladesh's 2.34% GDP expenditure on healthcare, hinder the availability and adoption of advanced devices.

Market Trends

A key trend is the shift toward automatic/pressure-activated safety lancets, favored for their automatic needle retraction and reduced risk of injury. Studies indicate that automatic lancets cause less pain and improve efficiency in both clinical and home care settings.

Segmentation Analysis

By Type:

  • Button-activated lancets dominate, holding 62.57% market share in 2026, due to ease of use and simple activation mechanisms.
  • Pressure/contact-activated lancets offer consistent puncture depth and enhanced safety, with increasing adoption in developed regions.

By Incision Type:

  • Needle lancets dominate due to safety features and reduced pain.
  • Blade lancets are growing, especially for neonatal screening and dried blood spot tests, providing higher blood volumes for certain diagnostics.

By Age Group:

  • Adults dominate due to frequent blood glucose, HbA1c, and cholesterol testing.
  • Pediatrics are witnessing growth due to type 1 diabetes monitoring and SMBG recommendations.

By Application:

  • Blood glucose monitoring leads with 59.67% market share in 2026, driven by diabetes prevalence.
  • Hemoglobin testing is projected for the fastest growth, while cholesterol testing shows moderate adoption.
  • Other applications include lipid profiling, coagulation monitoring, and dried blood spot tests.

By End-user:

  • Hospitals & clinics lead with 41.40% market share in 2026 due to patient visits and assisted monitoring programs.
  • Home care is expected to achieve the highest CAGR due to SMBG adoption.
  • Others include blood banks, diagnostic labs, academic institutions, and nursing homes.

Regional Outlook

  • North America: Market value of USD 0.46 billion in 2025, reaching USD 0.51 billion in 2026, driven by high diabetes prevalence and strong reimbursement policies.
  • Europe: Key markets include the U.K. (USD 0.03 billion in 2026) and Germany (USD 0.10 billion in 2026) due to advanced healthcare infrastructure.
  • Asia Pacific: Projected highest CAGR with Japan (USD 0.04 billion), China (USD 0.15 billion), and India (USD 0.08 billion) in 2026, supported by domestic manufacturers and large diabetic populations.
  • Latin America: Growth due to rising healthcare expenditure and home monitoring demand.
  • Middle East & Africa: Steady growth attributed to diabetes awareness and favorable policies.

Competitive Landscape

The market is highly fragmented, with major players such as BD, HTL-STREFA, Abbott, Cardinal Health, B. Braun SE, Terumo Medical Corporation, SARSTEDT AG & Co. KG, and YPSOMED focusing on product innovation, geographic expansion, and distribution partnerships. Key industry developments include product launches, national agreements, and participation in global medical exhibitions.

Conclusion

The global safety lancets market is poised for substantial growth, from USD 1.21 billion in 2025 to USD 3.28 billion by 2034, driven by rising diabetes prevalence, home monitoring adoption, and technological advancements in lancet safety. North America remains the dominant market, while Asia Pacific offers the highest growth potential. Although high costs and limited healthcare spending in some regions present challenges, the increasing focus on patient safety and convenient monitoring solutions positions the market for sustained expansion. Key players with strong R&D and distribution networks are expected to consolidate their leadership, shaping the competitive landscape in the coming years.

Segmentation By Type

  • Button-activated
  • Pressure/Contact-activated

By Incision Type

  • Needle
  • Blade

By Age Group

  • Adult
  • Pediatric

By Application

  • Blood Glucose Monitoring
  • Hemoglobin Testing
  • Cholesterol Testing
  • Others

By End-user

  • Hospitals & Clinics
  • Home Care
  • Others

By Region

  • North America (By Type, Incision Type, Age Group, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries/Region, 2025
  • 4.2. Number of SMBG User, By Key Countries/Region, 2025
  • 4.3. Advancements in Safety Lancets
  • 4.4. Overview: Reimbursement Scenario
  • 4.5. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)

5. Global Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Button-activated
    • 5.1.2. Pressure/Contact-activated
  • 5.2. Market Analysis, Insights and Forecast - By Incision Type
    • 5.2.1. Needle
    • 5.2.2. Blade
  • 5.3. Market Analysis, Insights and Forecast - By Age Group
    • 5.3.1. Adult
    • 5.3.2. Pediatric
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Blood Glucose Monitoring
    • 5.4.2. Hemoglobin Testing
    • 5.4.3. Cholesterol Testing
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Hospitals & Clinics
    • 5.5.2. Home Care
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Button-activated
    • 6.1.2. Pressure/Contact-activated
  • 6.2. Market Analysis, Insights and Forecast - By Incision Type
    • 6.2.1. Needle
    • 6.2.2. Blade
  • 6.3. Market Analysis, Insights and Forecast - By Age Group
    • 6.3.1. Adult
    • 6.3.2. Pediatric
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Blood Glucose Monitoring
    • 6.4.2. Hemoglobin Testing
    • 6.4.3. Cholesterol Testing
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Home Care
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Button-activated
    • 7.1.2. Pressure/Contact-activated
  • 7.2. Market Analysis, Insights and Forecast - By Incision Type
    • 7.2.1. Needle
    • 7.2.2. Blade
  • 7.3. Market Analysis, Insights and Forecast - By Age Group
    • 7.3.1. Adult
    • 7.3.2. Pediatric
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Blood Glucose Monitoring
    • 7.4.2. Hemoglobin Testing
    • 7.4.3. Cholesterol Testing
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Home Care
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia pacific Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Button-activated
    • 8.1.2. Pressure/Contact-activated
  • 8.2. Market Analysis, Insights and Forecast - By Incision Type
    • 8.2.1. Needle
    • 8.2.2. Blade
  • 8.3. Market Analysis, Insights and Forecast - By Age Group
    • 8.3.1. Adult
    • 8.3.2. Pediatric
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Blood Glucose Monitoring
    • 8.4.2. Hemoglobin Testing
    • 8.4.3. Cholesterol Testing
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Hospitals & Clinics
    • 8.5.2. Home Care
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Button-activated
    • 9.1.2. Pressure/Contact-activated
  • 9.2. Market Analysis, Insights and Forecast - By Incision Type
    • 9.2.1. Needle
    • 9.2.2. Blade
  • 9.3. Market Analysis, Insights and Forecast - By Age Group
    • 9.3.1. Adult
    • 9.3.2. Pediatric
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Blood Glucose Monitoring
    • 9.4.2. Hemoglobin Testing
    • 9.4.3. Cholesterol Testing
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Hospitals & Clinics
    • 9.5.2. Home Care
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Button-activated
    • 10.1.2. Pressure/Contact-activated
  • 10.2. Market Analysis, Insights and Forecast - By Incision Type
    • 10.2.1. Needle
    • 10.2.2. Blade
  • 10.3. Market Analysis, Insights and Forecast - By Age Group
    • 10.3.1. Adult
    • 10.3.2. Pediatric
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Blood Glucose Monitoring
    • 10.4.2. Hemoglobin Testing
    • 10.4.3. Cholesterol Testing
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Hospitals & Clinics
    • 10.5.2. Home Care
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. BD
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. SARSTEDT AG & Co. KG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Greiner Bio-One International GmbH
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. HTL-STREFA (MTD Medical Technology and Devices)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Terumo Medical Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. B. Braun SE
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Abbott
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Cardinal Health
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. YPSOMED
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Biosense Technologies Private Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1:Global Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2:Global Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 3:Global Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 4:Global Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5:Global Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 6:Global Safety Lancets Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7:North America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8:North America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 9:North America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 10:North America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11:North America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 12:North America Safety Lancets Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 15:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 16:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17:Europe Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 18:Europe Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 21:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 22:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 24:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 27:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 28:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 30:Latin America Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 33:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 34:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 36:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1:Global Safety Lancets Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2:Global Safety Lancets Market Value Share (%), by Type, 2025 & 2034
  • Figure 3:Global Safety Lancets Market Value Share (%), by Incision Type, 2025 & 2034
  • Figure 4:Global Safety Lancets Market Value Share (%), by Age Group, 2025 & 2034
  • Figure 5:Global Safety Lancets Market Value Share (%), by Application, 2025 & 2034
  • Figure 6:Global Safety Lancets Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7:Global Safety Lancets Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8:North America Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 9:North America Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 10:North America Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 11:North America Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 12:North America Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 13:North America Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 14:North America Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 15:North America Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 16:North America Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 17:North America Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 18:North America Safety Lancets Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19:North America Safety Lancets Market Value Share (%), By Country, 2025
  • Figure 20:Europe Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 21:Europe Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 22:Europe Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 23:Europe Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 24:Europe Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 25:Europe Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 26:Europe Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27:Europe Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 28:Europe Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29:Europe Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 30:Europe Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 31:Europe Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
  • Figure 32:Asia Pacific Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 33:Asia Pacific Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 34:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 35:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 36:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 37:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 38:Asia Pacific Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 39:Asia Pacific Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 40:Asia Pacific Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 41:Asia Pacific Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 42:Asia Pacific Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 43:Asia Pacific Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
  • Figure 44:Latin America Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 45:Latin America Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 46:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 47:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 48:Latin America Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 49:Latin America Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 50:Latin America Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 51:Latin America Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 52:Latin America Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 53:Latin America Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 54:Latin America Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 55:Latin America Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
  • Figure 56:Middle East & Africa Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 57:Middle East & Africa Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 58:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 59:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 60:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 61:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 62:Middle East & Africa Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 63:Middle East & Africa Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 64:Middle East & Africa Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 65:Middle East & Africa Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 66:Middle East & Africa Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 67:Middle East & Africa Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
  • Figure 68:Global Safety Lancets Market Share (%), By Company, 2025